ORIGINAL RESEARCH article
Front. Cell Dev. Biol.
Sec. Cancer Cell Biology
Volume 13 - 2025 | doi: 10.3389/fcell.2025.1619359
This article is part of the Research TopicNew Advancement in Tumor Microenvironment Remodeling and Cancer Therapy, Volume IIView all 6 articles
MiR-145-5p arrests the cell cycle by modulating SMAD5/Cyclin D1 to inhibit gastric cancer progression
Provisionally accepted- 1Shanxi Medical University, Taiyuan, China
- 2Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi Province, China
- 3Tianjin Medical University, Tianjin, Tianjin Municipality, China
- 4Shanxi Provincial People's Hospital, Taiyuan, Shanxi Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Purpose : This study aimed to explore the dysregulation of miR-145-5p in gastric cancer(GC) and its effects on the proliferation and cell cycle of GC cells, exploring the potential regulatory mechanism of miR-145-5p in GC. Methods:In this study, the TCGA database combined with Microarray was used to detect differentially expressed microRNA (miRNA) in GC tissues and cells. Quantitative real-time (qRT)-PCR was used to further verify the expression of miR-145-5p in GC cells and the 41 pairs of GC tissues and adjacent tissues. A retrospective analysis was conducted on the correlation between miR-145-5p and the clinicopathological characteristics of patients interfering RNA; ceRNAs, competitive endogenous RNAs; qRT-PCR, quantitative reverse transcription polymerase chain reaction.
Keywords: Mir-145-5p, Smad5, gastric cancer, Cyclin D1, Cell Cycle
Received: 28 Apr 2025; Accepted: 10 Jul 2025.
Copyright: © 2025 Li, Guo, Caixia, Luke, Jing, Wang, Yuanyuan, Ruirui, Tao, Feng and Baofeng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Guan Tao, Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi Province, China
Li Feng, Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi Province, China
Yu Baofeng, Shanxi Medical University, Taiyuan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.